Life Scientist > Biotechnology

AstraZeneca vaccine arrives in Aus, Pfizer prevents infection

01 March, 2021

The first doses of AstraZeneca's COVID-19 vaccine have arrived in Sydney, and new data suggests that Pfizer's vaccine can reduce asymptomatic infections.

Second-gen lung-on-chip developed

26 February, 2021

Scientists have created a second-generation lung-on-chip model with life-size dimension alveoli in a stretchable membrane, made of purely biological material.

Nanoparticles boost the immune system to fight cancer

23 February, 2021

A new nanoparticle-based drug can boost the body's innate immune system and make it more effective at fighting off tumours, according to researchers.

TGA approves AstraZeneca vaccine, Pfizer doses arrive in Aus

16 February, 2021

The TGA has granted provisional approval to AstraZeneca for its COVID-19 vaccine, one day after >142,000 doses of Pfizer's vaccine arrived at Sydney Airport.

A rift in the retina helps transplanted cells better integrate

15 February, 2021

Researchers have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases.

Oral ketamine can be used to reduce chronic suicidality

10 February, 2021

Within six weeks of treatment, 69% of participants achieved a clinical reduction in suicide ideation — and half noted significant improvement after treatment had ceased.

10m more COVID-19 vaccines for Aus; Russia's efficacy results

05 February, 2021

The Australian Government acquires another 10 million doses of Pfizer and BioNTech's vaccine and Russia announces promising phase 3 trial results.

3D-printed stents deliver drugs for oesophageal cancer

05 February, 2021

The stents' composition allows them to deliver up to 110 days of a sustained anticancer medication directly to the cancer site.

The antibiotic potential of CBD

03 February, 2021

Researchers have shown that synthetic cannabidiol — better known as CBD — can kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires' disease.

Novavax COVID-19 vaccine demonstrates 89.3% efficacy

31 January, 2021

NVX-CoV2373, a protein-based COVID-19 vaccine candidate, has demonstrated efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.

TGA approves Pfizer and BioNTech's COVID-19 vaccine

25 January, 2021

The Therapeutic Goods Administration (TGA) has granted provisional approval to Pfizer Australia for its COVID-19 vaccine, developed in partnership with BioNTech.

8 myths about mRNA COVID-19 vaccines explained

20 January, 2021

Dr Thaddeus Stappenbeck dispels fears about the new generation of vaccines and explains that they cannot alter your DNA or give you COVID-19.

Drug inhibits cancer cell growth by attacking mitochondria

15 January, 2021

A newly developed compound starves cancer cells by attacking their 'power plants', by preventing the genetic information within mitochondria from being read.

Oral insulin nanoparticles could replace injections

14 January, 2021

Scientists have developed insulin nanoparticles that may one day become the basis for an oral medicine — and an alternative to insulin injections for diabetic patients.

Aus COVID-19 vaccine rollout brought forward to February

08 January, 2021

Prime Minister Scott Morrison says the first groups are expected to receive a jab as early as the middle of the month.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd